Drug
Metyrosine
Metyrosine: highest development phase Phase 2, developed by Bausch Health. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Bausch Health
Trials
| Drug | Phase | Indication |
|---|---|---|
| Metyrosine NCT01127503 | Phase 2 | Velo-cardio-facial Syndrome |
Latest
No recent events.
Follow Metyrosine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.